BackAllakos Overview

Allakos Other Current Liabilities

Latest other current liabilities for ALLK: $4M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$4.00M
76.65% YoYΔ $-13.15M vs prior year quarter

Peer average / median

Loading

Allakos Other Current Liabilities History

Loading

Allakos vs. peers: Other Current Liabilities Comparison

Loading

Allakos Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Allakos (ALLK) FAQ

Allakos's other current liabilities stands at $4M as of March 2025. That compares with $17M in the prior-year period — down 76.7% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Allakos reported $4M in other current liabilities versus $17M a year earlier — a 76.7% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $17M in the prior-year period — down 76.7% year over year. Sustained growth in other current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Allakos's other current liabilities evolved across reporting periods, while the comparison chart places ALLK next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, other current liabilities is commonly used to spot outliers. Allakos's reading of $4M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.